For over 20 years, we have focused on the design, development, manufacture, and sale of patented laser technologies. Our superpulsed, dual-wavelength lasers are safe and effective, allowing your patients to start Healing at the Speed of Light®
Free Webinar - December 12, 2018
In this webinar, Dr. Elizabeth Angelevski, D.C., will discuss how therapeutic laser technology can improve performance, enhance muscle, and accelerate recovery in athletes.
Healing at the Speed of Light®
We also design, manufacture and distribute patented and proprietary super-pulsed cool laser technology for the treatment of knee pain, and in off-label use, the treatment of numerous nerve, muscle and joint conditions.
Free Workshops - October to December 2018
This workshop is excellent for the clinician who wants to effectively learn about Theralase® laser treatments in the clinic to promote healing.
We are a Canadian clinical stage pharmaceutical company dedicated to the research and development of light-activated Photo Dynamic Compounds and their associated drug formulations to safely and effectively destroy cancer.
Super-Pulsed Cool Laser Technology
With up to 4 probes, the versatile TLC-2000 series helps you treat multiple conditions at the same time, or multiple patients simultaneously, enhancing productivity, growing revenue, and driving patient satisfaction.
We are Hiring!
We are expanding our team and have the following full time positions available immediately: Marketing Coordinator, Public Relations Coordinator, Investor Relations Coordinator.
Completed Phase 1b Clinical Study
Our laser systems have been used to treat over 1,000,000 patients worldwide, and our anti-cancer technology has now successfully completed a Phase 1b Clinical Study for Non-Muscle Invasive Bladder Cancer ("NMIBC").
Theralase® Technologies Inc. is a biopharmaceutical company headquartered in Toronto, Canada focused on the design, development, manufacturing, and sale of patented laser technology platforms used in a wide range of bio-stimulative and bio-destructive clinical applications in patients.
Founded in 1994, Theralase’s operations are divided into two divisions: the production of therapeutic laser technology for commercial applications, and the research and development of laser-based technologies for the destruction of cancer cells and other disease states.
Therapeutic Laser Technology Division
Theralase® focuses on the development of laser-based of laser-based non-invasive therapeutic devices to eliminate pain, reduce inflammation, and accelerate tissue healing.
Theralase® develops advanced pharmaceutical products and medical devices based on proprietary non-immunosuppressive photodynamic technology, targeting high anti-cancer effectiveness, microbial sterilization potency, and bacterial infection control.